Sale!

SCN2A Gene Early infantile epileptic encephalopathy type 11 Genetic Test

4,400 د.إ

-21%

The SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 Genetic Test is a specialized diagnostic tool used to identify mutations in the SCN2A gene, which are linked to Early Infantile Epileptic Encephalopathy Type 11 (EIEE11). This condition is a severe form of epilepsy that begins in infancy and is characterized by frequent seizures and significant developmental delays. The test is crucial for early diagnosis and management of the condition, allowing healthcare providers to tailor treatment plans to the individual needs of the patient.

Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the SCN2A gene. The accuracy and reliability of the test make it a valuable resource for families seeking answers to complex neurological conditions.

The cost of the SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 Genetic Test is 4400 AED. While the price may seem significant, the insights provided by the test can be invaluable in guiding the clinical management of affected individuals, potentially improving outcomes and quality of life.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 Genetic Test

At DNA Labs UAE, we offer the SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 Genetic Test. This test is designed to analyze the DNA sequence of the SCN2A gene in order to detect any mutations or variations that may be associated with Early Infantile Epileptic Encephalopathy Type 11 (EIEE11), a rare genetic disorder characterized by seizures that begin in the first few months of life.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

The report for the SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 Genetic Test is typically delivered within 3 to 4 weeks.

Method

The test utilizes NGS (Next-Generation Sequencing) technology to analyze the DNA sequence of the SCN2A gene.

Test Type

The SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 Genetic Test falls under the category of Neurological Disorders.

Doctor

This test is recommended by Neurologists.

Test Department

The test is conducted in our Genetics department.

Pre Test Information

Prior to undergoing the SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session is conducted to draw a pedigree chart of family members affected with SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11.

Test Details

The SCN2A gene is associated with Early Infantile Epileptic Encephalopathy Type 11 (EIEE11), a rare genetic disorder characterized by seizures that begin in the first few months of life. The NGS genetic test for the SCN2A gene analyzes the DNA sequence of the gene to detect any mutations or variations that may be associated with EIEE11. This test can help diagnose the disorder and provide important information for genetic counseling and treatment. It is typically recommended for individuals who have symptoms of EIEE11 or a family history of the disorder.

Test Name SCN2A Gene Early infantile epileptic encephalopathy type 11 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SCN2A Gene Early infantile epileptic encephalopathy type 11 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCN2A Gene Early infantile epileptic encephalopathy type 11
Test Details

The SCN2A gene is associated with Early Infantile Epileptic Encephalopathy Type 11 (EIEE11), a rare genetic disorder characterized by seizures that begin in the first few months of life. The NGS genetic test for SCN2A gene analyzes the DNA sequence of the gene to detect any mutations or variations that may be associated with EIEE11. This test can help diagnose the disorder and provide important information for genetic counseling and treatment. It is typically recommended for individuals who have symptoms of EIEE11 or a family history of the disorder.